Dr. Kris Radcliff to Highlight MR Spectroscopy and Augmented Intelligence (AI)-Based Platform at State of Spine Surgery Think TankBROOMFIELD, Colo., June 24, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its participation in the upcoming State of Spine Surgery Thi ...

Core Insights - Medtronic plc has appointed Dr. Joon Lee, CEO of Emory Healthcare, as an independent director on its Board, effective June 18, 2025 [1] - Dr. Lee will contribute to the Science and Technology Committee and Compensation and Talent Committee [1] Company Overview - Medtronic is a global leader in healthcare technology, headquartered in Galway, Ireland, with a mission to alleviate pain, restore health, and extend life [6] - The company employs over 95,000 people across more than 150 countries and addresses 70 health conditions with its technologies [6] Dr. Joon Lee's Background - Dr. Lee has over 25 years of experience at the University of Pittsburgh Medical Center (UPMC), where he held significant roles including Executive Vice President and President of Physician Services [3] - He has a strong background in cardiology, having served as Chief of the Division of Cardiology and founding executive director of the UPMC Heart and Vascular Institute [4] - Dr. Lee's educational credentials include a BA from Dartmouth College and an MD from Duke University, along with extensive training in cardiology at Massachusetts General Hospital [5] Financial and Operational Insights - Emory Healthcare, under Dr. Lee's leadership, generates $7.7 billion in annual revenue and operates 12 hospitals with over 29,000 employees [2] - Dr. Lee also served as Chief Medical Officer of UPMC Insurance Services, which is a $13 billion health insurance division [4] Strategic Vision - Dr. Lee is recognized for his commitment to leveraging data and technology to enhance patient and provider experiences, aligning with Medtronic's mission [2]

Core Points - Treatment.com AI Inc. has granted 799,920 restricted share units (RSUs) and 162,480 stock options to its officers, directors, consultants, and employees [1][2] - The stock options are exercisable at C$0.50 per share for three years and vest over one year, while 700,000 RSUs are valid for five years and 99,920 RSUs for three years, all vesting over one year [2] - The company has engaged FN Media Group for a one-day news/media marketing campaign for USD$4,295 during the week of June 23 - June 27, 2025 [3][4] Company Overview - Treatment.com AI utilizes artificial intelligence and clinical best practices to enhance the healthcare sector, addressing inefficiencies and challenges [5] - The company has developed the Global Library of Medicine (GLM), a comprehensive AI engine that provides over 10,000 expert medical reviews, supporting healthcare professionals with clinical information, recommended tests, and billing codes [5] - The GLM aims to reduce administrative burdens for healthcare professionals, allowing more time for patient interactions and improving the consistency of patient support [5]

This presentation and the accompanying oral presentation, if any, contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements as to future results of operations and financial position, planned products and services, business strategy and plans, objectives of management for future operations of Health Catalyst, Inc. and its subsidiaries ("Health Catalyst" or the "Company"), market size and growth opportunities, competitive p ...

HealthStream。 1Q 2025 Investor Presentation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ©2025 HealthStream HealthStream. Safe Harbor Statement This presentation includes certain forward-looking statements (statements other than solely with respect to historical fact), including statements regarding expectations for the financial performance for 2025 that involve risks and uncertainties regarding HealthStream. These statements are based upon management's beliefs, as we ...

Doximity (NYSE: DOCS ) provides a digital platform for U.S. medical professionals with 2 million members, covering 80% of U.S. physicians. Its platform enables healthcare professionals to access the latest medical information, recruit staff, and streamline clinical workflows. I view Doximity as the "LinkedIn" for healthcare professionals, and I am initiatingAnalyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such posi ...

Walking around this 1,670 acre headquarters in Wisconsin, I found myself asking the same question. Why are there air tags on fake sheep. Why are you here.Why is there a giant chest set. Why. Why is there a slide in the middle of the hallway.Why. Why. Why.Really, the question is why not. Wow. All right.This is the headquarters of Epic with five different campuses. Some that take cues from stories like Harry Potter and the Wizard of Oz. Close to 13,000 employees come 5 days a week where they can browse this t ...

Core Insights - Doximity, Inc. has developed a client engagement and retention strategy centered on integrated, physician-first tools across its Marketing, Hiring, and Workflow Solutions, resulting in over 620,000 unique providers using its clinical tools in Q4 of fiscal 2025 [1] Group 1: Marketing Solutions - Doximity's Marketing Solutions utilize AI and machine learning to deliver personalized campaigns, enabling pharmaceutical and health system clients to effectively reach specific clinician segments with relevant content [2] - This targeted approach has led to measurable engagement, prompting clients to broaden their usage across various brands or service lines [2] Group 2: Customer Retention Strategies - The company invests in a robust customer success team that collaborates with clients to optimize campaigns and provide ongoing analytics, which has fostered upsell opportunities and long-term relationships [3] - Clients benefit from a self-serve portal that offers real-time insights, enhancing the overall customer experience [3] Group 3: Workflow Solutions - Doximity's Workflow Solutions, such as Dialer Enterprise and AMiON, have gained significant traction and are now integrated into hospital operations, reducing the likelihood of clients transitioning away from the platform [4] - Recent innovations like Doximity GPT, an AI-powered writing assistant, further alleviate administrative burdens for clients [4] Group 4: Competitive Landscape - GoodRx Holdings, Inc. has launched Community Link to enhance pharmacy engagement through cost-plus pricing, while also introducing a new erectile dysfunction subscription service to streamline consumer access [5] - Veeva Systems Inc. is enhancing client engagement through its Vault CRM Suite, which integrates medical, sales, and service teams, and has reported momentum in products that provide real-time insights [6] Group 5: Financial Performance - Doximity's shares have increased by 9.6% year-to-date, contrasting with the industry's decline of 0.9% [7] - The Zacks Consensus Estimate indicates a 3.5% improvement in Doximity's earnings per share for fiscal 2026 compared to fiscal 2025 [9] - The company's forward 12-month P/E ratio stands at 39.4X, higher than the industry average of 14.6X but lower than its three-year median of 48.9X [12]

The MES is a scalable platform designed to reduce administrative and faculty time, improve objectivity, increase evaluation consistency, and provide a robust digital infrastructure to support both live and AI-simulated formats. The focus of the platform is to help enhance the clinical skills of our next generation of healthcare professionals. By incorporating curated AI-generated cases and the supportive services provided by Treatment, the system enables: "Partnering with Treatment.com AI gave us the opport ...

Summary of SS&C (SSNC) 2025 Conference Call Company Overview - **Company**: SS&C Technologies Holdings, Inc. (SSNC) - **Industry**: Financial Services, specifically focusing on fund administration, IT services, and healthcare technology Key Points and Arguments Business Performance and Demand - SS&C has a strong position in fund administration, being the largest provider globally, which is essential for clients regardless of macroeconomic conditions [3][4] - The company experiences macroeconomic effects primarily in transaction-oriented businesses, such as order management systems, which are influenced by market volatility [4][10] - Demand remains healthy across most markets, with a full pipeline of opportunities and a competitive edge in technology and service offerings [11][12] Revenue and Growth Insights - Organic growth for Q1 was reported at 5.1%, with recurring financials at 5.9%, while Q2 guidance is around 2.5% [20][22] - The slowdown in Q2 is attributed to seasonal factors, with expectations for stronger performance in the latter half of the year due to previously sold deals and acquisitions [22][23] - The private markets segment within fund administration is growing over 10%, indicating a robust appetite for private equity and credit [29][31] Competitive Landscape - SS&C competes with large custodian banks and smaller fintech startups, leveraging its ability to innovate rapidly compared to heavily regulated organizations [13][15] - The company is well-positioned to displace outdated systems within client organizations, as many clients are reluctant to change from long-standing internal systems [16][19] Healthcare Segment - The healthcare business is expected to show flattish to slightly positive growth, with a focus on new platforms like DomaneRx, which has processed over 200 million claims [47][48] - The healthcare segment is seen as a smaller part of SS&C's overall business but with significant growth potential [56] Margin Expansion and Efficiency - SS&C has historically achieved margin expansion and continues to identify opportunities for improvement through technology deployment [57][59] - The acquisition of Blue Prism has allowed the company to enhance operational efficiency, saving approximately 2,500 positions, which is about 10% of the workforce [58][59] M&A Activity and Future Outlook - SS&C is actively looking for acquisition opportunities that align with its growth strategy, particularly in areas that can enhance its service offerings [79] - The company has announced a stock buyback program, indicating confidence in its stock and future performance [79] Market Opportunities - SS&C sees potential in underserved markets like Australia and the Middle East, where there is a demand for sophisticated technology and services [34][43] - The company is optimistic about expanding its presence in these regions, leveraging its existing expertise and client relationships [35][39] Additional Important Insights - The competitive environment in Australia includes custodial banks and independent firms, with SS&C's combined service and technology offering being a key differentiator [42] - The healthcare technology landscape is characterized by outdated systems, providing SS&C with an opportunity to introduce modern solutions [53][55] - The company emphasizes the importance of providing high-value, mission-critical services, which are less sensitive to pricing pressures from clients [71][72]